SUBSCRIBE
SUBSCRIBE

FDA Approves Once-Daily Lurasidone HCI for Schizophrenia

October 29, 2010 | 
1 min read
Idsk -- Lurasidone, an atypical antipsychotic, has been approved for treating adults with schizophrenia, the Food and Drug Administration announced Oct. 28.